Outcome of patients receiving V-V ECMO for SARS-CoV-2 severe acute respiratory failure
Saved in:
| Main Authors: | I.S. Morris, H. Taylor, D. Fleet, F. Y Lai, M. Charlton, J.W. Tang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis
2023-05-01
|
| Series: | Pulmonology |
| Online Access: | https://www.tandfonline.com/doi/10.1016/j.pulmoe.2023.01.001 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SARS-CoV-2, Pneumonia, Mortality, Severe Acute Respiratory Syndrome
by: Gloria Celeste Samudio-Domínguez
Published: (2025-01-01) -
SARS-CoV2 neuroinvasive potential in respiratory failure in COVID-19 patients
by: Hamidreza Hassanzadeh Khanmiri, et al.
Published: (2023-04-01) -
A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2.
by: Kwang Su Kim, et al.
Published: (2021-03-01) -
Respiratory Protective Equipment Reconsiderations in the Age of SARS-CoV-2
by: Wei-Ren Ke, et al.
Published: (2022-01-01) -
Lung transplant after 6 months on ECMO support for SARS-CoV-2-induced ARDS complicated by severe antibody-mediated rejection
by: Johan Nilsson, et al.
Published: (2021-01-01)